Literature DB >> 650356

Cardiac catheterization in the neonate. A comparison of three techniques.

C J Porter, P C Gillette, C E Mullins, D G McNamara.   

Abstract

This study evaluated three methods of catheter entry for cardiac catheterization in neonates less than one week of age. Eighty-five neonates underwent venous catheterization through the umbilical vein, 77 by saphenous or femoral cutdown, and 31 by femoral percutaneous entry. Of these 194 neonates, 128 also had an aortic catheter introduced via the umbilical artery. Umbilical vein catheterizations took an average of 115 minutes, 30 minutes shorter than either of the other techniques. Fatal complications following catheterization occurred in 10 of the 194 neonates (5%) three of these were related to catheterization technique. Diagnostic cardiac catheterization and balloon atrial septostomy may be performed most quickly by way of the umbilical vessels. Percutaneous entry of the femoral vein in this series carried the lowest complication rate; cutdown entry resulted in the highest complication rate.

Entities:  

Mesh:

Year:  1978        PMID: 650356     DOI: 10.1016/s0022-3476(78)80614-3

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  4 in total

Review 1.  Contributions of the Texas Children's Hospital Pediatric Cardiology Program to the field of pediatric cardiology.

Authors:  J T Bricker
Journal:  Tex Heart Inst J       Date:  1997

2.  Acquired deep venous thrombosis in children.

Authors:  A Marcinski; V Barral; J Sauvegrain
Journal:  Pediatr Radiol       Date:  1985

3.  Venous blood flow in the leg after ligation of the femoral vein during cardiac catheterization in young children.

Authors:  G Nielsen; J E Lorentzen
Journal:  Pediatr Cardiol       Date:  1986       Impact factor: 1.655

4.  Complications of Cardiac Catheterization in Structural Heart Disease.

Authors:  Ko Eun Lee; Yeon Jeong Seo; Gi Beom Kim; Hyo Soon An; Young Hwan Song; Bo Sang Kwon; Eun Jung Bae; Chung Il Noh
Journal:  Korean Circ J       Date:  2016-03-21       Impact factor: 3.243

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.